FDA approves Rasonque for pancreatic cancer

The United States Food and Drug Administration (FDA) announced the approval of a new treatment named Rasonque for pancreatic cancer on Wednesday. The announcement marks a significant development in the medical approach to one of the deadliest forms of the disease.

According to the provided reports, the newly approved therapy is described as a promising treatment that opens a new era in addressing pancreatic cancer. The drug was developed to target this specific and highly lethal type of cancer.